MEF2C and meningioma: Recent studies have shown that MEF2C silencing downregulates NF2 and E-cadherin and enhances ferroptosis in meningiomas, suggesting that NF2 loss or low E-cadherin expression predisposes meningiomas to ferroptosis [14].